ADB-HEXINACA is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC).

Synthetic cannabinoids have caused adverse events, including deaths. ADB-PINACA and ADB-BINACA (ADB-BUTINACA) are structurally similar synthetic cannabinoids.

ADB-PINACA is a Schedule I substance in the United States; ADB-HEXINACA is not explicitly federally scheduled, although this drug may be controlled under individual state regulations.

ADB-HEXINACA has been identified in 2021 at the Pinellas County Forensic Lab in Florida.

See NPS Discovery Report

« Back to Glossary Index

Copyright © 2023 - NADDI. All Rights Reserved.

Disclaimer / Privacy Policy / Copyright Policy

Log in with your credentials

Forgot your details?